SK212000A3 - 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy - Google Patents

6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy Download PDF

Info

Publication number
SK212000A3
SK212000A3 SK21-2000A SK212000A SK212000A3 SK 212000 A3 SK212000 A3 SK 212000A3 SK 212000 A SK212000 A SK 212000A SK 212000 A3 SK212000 A3 SK 212000A3
Authority
SK
Slovakia
Prior art keywords
mixture
dihydro
compound
pyrindine
pyrrolidin
Prior art date
Application number
SK21-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Alistair Lochead
Samir Jegham
Frederic Galli
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of SK212000A3 publication Critical patent/SK212000A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK21-2000A 1997-07-09 1998-07-07 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy SK212000A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9708706A FR2765874B1 (fr) 1997-07-09 1997-07-09 Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique
PCT/FR1998/001446 WO1999002517A1 (fr) 1997-07-09 1998-07-07 Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
SK212000A3 true SK212000A3 (en) 2000-06-12

Family

ID=9509040

Family Applications (1)

Application Number Title Priority Date Filing Date
SK21-2000A SK212000A3 (en) 1997-07-09 1998-07-07 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy

Country Status (21)

Country Link
US (1) US6184229B1 (fr)
EP (1) EP1000056A1 (fr)
JP (1) JP2002508004A (fr)
KR (1) KR20010021617A (fr)
CN (1) CN1262680A (fr)
AR (1) AR013192A1 (fr)
AU (1) AU8544498A (fr)
BG (1) BG104037A (fr)
BR (1) BR9811672A (fr)
CA (1) CA2295666A1 (fr)
CO (1) CO4890850A1 (fr)
EE (1) EE200000018A (fr)
FR (1) FR2765874B1 (fr)
HU (1) HUP0003856A2 (fr)
IL (1) IL133536A0 (fr)
NO (1) NO20000066L (fr)
PL (1) PL338123A1 (fr)
SK (1) SK212000A3 (fr)
TR (1) TR200000057T2 (fr)
WO (1) WO1999002517A1 (fr)
ZA (1) ZA986047B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005126340A (ja) * 2003-10-22 2005-05-19 Kureha Chem Ind Co Ltd 置換ピリドン類の製造法、その原料化合物及びその製造方法
WO2006031856A2 (fr) 2004-09-13 2006-03-23 Chrono Therapeutics, Inc. Administration de medicament transdermique biosynchrone
JP2010523587A (ja) 2007-04-02 2010-07-15 パーキンソンズ インスティテュート 治療処置の副作用の低減のための方法および組成物
CA2974324A1 (fr) 2015-01-28 2016-08-04 Zita S. Netzel Procedes et systemes d'administration de medicament
WO2018129304A1 (fr) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Dispositifs et methodes d'administration transdermique de medicament
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227391A (en) * 1992-04-10 1993-07-13 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5232933A (en) * 1992-05-21 1993-08-03 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
WO1999002517A1 (fr) 1999-01-21
HUP0003856A2 (hu) 2001-10-28
BG104037A (en) 2001-04-30
FR2765874B1 (fr) 1999-08-13
NO20000066D0 (no) 2000-01-06
IL133536A0 (en) 2001-04-30
KR20010021617A (ko) 2001-03-15
ZA986047B (en) 1999-02-01
TR200000057T2 (tr) 2000-08-21
PL338123A1 (en) 2000-09-25
CO4890850A1 (es) 2000-02-28
BR9811672A (pt) 2000-09-19
AR013192A1 (es) 2000-12-13
CA2295666A1 (fr) 1999-01-21
CN1262680A (zh) 2000-08-09
EP1000056A1 (fr) 2000-05-17
NO20000066L (no) 2000-03-09
EE200000018A (et) 2000-08-15
JP2002508004A (ja) 2002-03-12
FR2765874A1 (fr) 1999-01-15
US6184229B1 (en) 2001-02-06
AU8544498A (en) 1999-02-08

Similar Documents

Publication Publication Date Title
FI91401B (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi
CN101243083A (zh) 萘啶化合物
FR2786769A1 (fr) Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
JP2009519282A (ja) 精神病および神経変性障害の処置のための、ｎ−ＡＣｈＲのコリン作動性リガンドとしての（１−アザ−ビシクロ［３．３．１］ノン−４−イル）−［５−（１Ｈ−インドール−５−イル）−ヘテロアリール］−アミン
CN101243082A (zh) 治疗cns障碍的六氢－吡咯并－异喹啉化合物
JP2020502184A (ja) 疼痛および疼痛に関連する状態を処置するための新規なキノリンおよびイソキノリン誘導体
CN111867585A (zh) 噁二唑瞬时受体电位通道抑制剂
SK12422001A3 (sk) Deriváty pyridopyranoazepínu, spôsob ich prípravy, liečivo a farmaceutická kompozícia s ich obsahom
TW200303312A (en) 4-(Oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]nonane derivatives, their preparation and their application in therapeutics
CA2171579A1 (fr) Derives de la piperidine; methode de preparation et utilisation a des fins therapeutiques
JP5134755B2 (ja) ４−（オキサゾロピリジン−２−イル）−１，４−ジアザビシクロ−［３．２．２］ノナン誘導体、それらの製造と治療的使用
JPWO2002060907A1 (ja) 複素環化合物及びそれを有効成分とする脳機能改善剤
SK212000A3 (en) 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy
WO2010007032A1 (fr) Urées à base de pipéridine en tant qu’antagonistes du nk1
US6143761A (en) 2,3-dihydrofuro [3,2-β]pyridin, preparation and application thereof in therapy
EP2496579B1 (fr) 2-azabicyclo[3.1.1]heptyl dérivés 1-substitués utiles en tant que modulateurs du récepteur nicotinique d'acétylcholine pour traiter des troubles neurologiques
JP4402957B2 (ja) ５−（ピリジン−３−イル）−１−アザビシクロ［３．２．１］オクタン誘導体類、それらの製造と治療におけるそれらの適用
JP2022509434A (ja) 疼痛に対して活性があるピペラジニル及びピペリジニルキナゾリン－４（３ｈ）－オン誘導体
CZ139298A3 (cs) Amidinové a isothiomočovinové deriváty jako inhibitory synthasy oxidu dusičného
IL128902A (en) History - N- (2-Benzothiazol) - 1 piperidinethanamine, their preparation and pharmaceutical preparations containing them
JP2005514422A6 (ja) ５−（ピリジン−３−イル）−１−アザビシクロ［３．２．１］オクタン誘導体類、それらの製造と治療におけるそれらの適用
CZ200030A3 (cs) Deriváty 6-pyrrolidin-2-ylpyrindinů, způsob jejich přípravy a farmaceutický prostředek, který je obsahuje
CN101878201B (zh) 稠合茚满化合物
MXPA00000352A (en) 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy
JP7390401B2 (ja) 縮合環化合物、その製造方法及び用途